Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 17980500)

1.

On the need to compensate for edema-induced dose reductions in preplanned (131)Cs prostate brachytherapy.

Chen ZJ, Deng J, Roberts K, Nath R.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):303-10. Epub 2007 Nov 5.

2.

Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters.

Sinha N, Cifter G, Sajo E, Kumar R, Sridhar S, Nguyen PL, Cormack RA, Makrigiorgos GM, Ngwa W.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):385-92. doi: 10.1016/j.ijrobp.2014.10.001. Epub 2014 Dec 5.

PMID:
25482302
3.

Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies.

Wooten CE, Randall M, Edwards J, Aryal P, Luo W, Feddock J.

Gynecol Oncol. 2014 May;133(2):268-73. doi: 10.1016/j.ygyno.2014.02.015. Epub 2014 Feb 17.

4.

Determination of prescription dose for Cs-131 permanent implants using the BED formalism including resensitization correction.

Luo W, Molloy J, Aryal P, Feddock J, Randall M.

Med Phys. 2014 Feb;41(2):024101. doi: 10.1118/1.4860255.

PMID:
24506655
5.

On the sensitivity of α/β prediction to dose calculation methodology in prostate brachytherapy.

Afsharpour H, Walsh S, Collins Fekete CA, Vigneault E, Verhaegen F, Beaulieu L.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):345-50. doi: 10.1016/j.ijrobp.2013.11.001.

PMID:
24411607
6.

Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes.

Kovtun KA, Wolfsberger L, Niedermayr T, Sugar EN, Graham PL, Murciano-Goroff Y, Beard C, D'Amico AV, Martin NE, Orio PF, Nguyen PL.

Brachytherapy. 2014 Mar-Apr;13(2):152-6. doi: 10.1016/j.brachy.2013.05.006. Epub 2013 Aug 2.

PMID:
23911279
7.

Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy.

Chen WC, Tokita KM, Ravera J, Fu P, Jiang Y, Kaminsky DA, Ponsky L, Ellis RJ.

Brachytherapy. 2013 Sep-Oct;12(5):422-7. doi: 10.1016/j.brachy.2012.09.003. Epub 2013 Feb 4.

PMID:
23380382
8.

Edema-induced changes in tumor cell surviving fraction and tumor control probability in 131Cs permanent prostate brachytherapy implant patients.

Kehwar TS, Jones HA, Huq MS, Smith RP.

J Appl Clin Med Phys. 2013 Jan 7;14(1):3862. doi: 10.1120/jacmp.v14i1.3862.

PMID:
23318378
9.

Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.

Lettmaier S, Lotter M, Kreppner S, Strnad A, Fietkau R, Strnad V.

Radiother Oncol. 2012 Aug;104(2):181-6. doi: 10.1016/j.radonc.2012.07.003. Epub 2012 Jul 30.

PMID:
22853851
10.

Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.

Ding W, Lee J, Chamberlain D, Cunningham J, Yang L, Tay J.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):962-7. doi: 10.1016/j.ijrobp.2012.01.043. Epub 2012 Apr 9.

PMID:
22494584
11.

Biochemical outcome after high-dose-rate intensity modulated brachytherapy with external beam radiotherapy: 12 years of experience.

Prada PJ, González H, Fernández J, Jiménez I, Iglesias A, Romo I.

BJU Int. 2012 Jun;109(12):1787-93. doi: 10.1111/j.1464-410X.2011.10632.x. Epub 2011 Oct 7.

PMID:
21981583
12.

Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer?

Morton G, Loblaw A, Cheung P, Szumacher E, Chahal M, Danjoux C, Chung HT, Deabreu A, Mamedov A, Zhang L, Sankreacha R, Vigneault E, Springer C.

Radiother Oncol. 2011 Sep;100(3):463-7. doi: 10.1016/j.radonc.2011.08.022. Epub 2011 Sep 14.

PMID:
21924511
13.

Timing of postseed imaging influences rectal dose-volume parameters for cesium-131 prostate seed implants.

Yaparpalvi R, Hannan R, Landau E, Kahan N, Bodner W, Kuo HC, Minsky L, Mehta KJ, Garg MK, Kalnicki S, Guha C.

Brachytherapy. 2012 Nov-Dec;11(6):489-94. doi: 10.1016/j.brachy.2011.07.004. Epub 2011 Aug 24.

PMID:
21868289
14.

The impact of prostate edema on cell survival and tumor control after permanent interstitial brachytherapy for early stage prostate cancers.

Chen ZJ, Roberts K, Decker R, Pathare P, Rockwell S, Nath R.

Phys Med Biol. 2011 Aug 7;56(15):4895-912. doi: 10.1088/0031-9155/56/15/016. Epub 2011 Jul 19.

15.

Greater postimplant swelling in small-volume prostate glands: implications for dosimetry, treatment planning, and operating room technique.

Chung E, Stenmark MH, Evans C, Narayana V, McLaughlin PW.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1944-8. doi: 10.1016/j.ijrobp.2011.03.024. Epub 2011 Jun 2.

PMID:
21640498
16.

Moving toward focal therapy in prostate cancer: dual-isotope permanent seed implants as a possible solution.

Todor DA, Barani IJ, Lin PS, Anscher MS.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):297-304. doi: 10.1016/j.ijrobp.2010.10.060. Epub 2011 Apr 30.

PMID:
21536392
17.

High-dose-rate monotherapy: safe and effective brachytherapy for patients with localized prostate cancer.

Demanes DJ, Martinez AA, Ghilezan M, Hill DR, Schour L, Brandt D, Gustafson G.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1286-92. doi: 10.1016/j.ijrobp.2010.10.015. Epub 2011 Feb 9.

PMID:
21310546
18.

High-dose-rate brachytherapy boost to the dominant intra-prostatic tumor region: hemi-irradiation of prostate cancer.

Schick U, Popowski Y, Nouet P, Bieri S, Rouzaud M, Khan H, Weber DC, Miralbell R.

Prostate. 2011 Sep;71(12):1309-16. doi: 10.1002/pros.21347. Epub 2011 Feb 9.

PMID:
21308714
19.

Influence of prostatic edema on 131Cs permanent prostate seed implants: a dosimetric and radiobiological study.

Kehwar TS, Jones HA, Huq MS, Smith RP.

Int J Radiat Oncol Biol Phys. 2011 Jun 1;80(2):621-7. doi: 10.1016/j.ijrobp.2010.07.001. Epub 2010 Oct 6.

PMID:
20932692
20.

Biochemical disease-free rate and toxicity for men treated with iodine-125 prostate brachytherapy with d(90) ≥180 Gy.

Gómez-Iturriaga Piña A, Crook J, Borg J, Ma C.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):422-7. doi: 10.1016/j.ijrobp.2009.07.1723.

PMID:
20832665
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk